165.86BMarket Cap-63630P/E (TTM)
29.320High28.990Low19.99MVolume29.160Open29.160Pre Close582.78MTurnover0.35%Turnover Ratio79.11P/E (Static)5.67BShares32.21952wk High1.89P/B165.63BFloat Cap24.48052wk Low1.66Dividend TTM5.66BShs Float54.716Historical High5.67%Div YieldTTM1.13%Amplitude5.477Historical Low29.156Avg Price1Lot Size
Pfizer Stock Forum
Baird's optimism is driven by promising developments in Instil’s PD-L1xVEGF bispecific antibody, especially following positive data from peers like Akeso and Summit. Analysts believe this drug class has strong potentia...
going
down
again
As of September 10, Pfizer's stock price has risen by about 7% since June 2024, which could be just the beginning of its growth momentum. The pharmaceutical giant's non-COVID product line has performed strongly, and Wall Street analysts are predicting that its earnings per share will bottom out in fiscal year 2024, indicating that Pfizer's recovery is just starting.
In the second quart...
This thing is going to move next week. if there is a pop, better get out while you still can. I will say told you so when it's at 630. Ha.....What that's not going to happen? I guess the meaning of overvalued doesn't exist in this generation. even at half price, this is still overvalued. The only way this thing is worth 1T is if LLY discovered a longevity pill.
$Pfizer (PFE.US)$
$SPDR S&P 500 ETF (SPY.US)$
The share price finally stays above 29 today. Hope to see it going to 30 and above next week✌️
$Intel (INTC.US)$ shares rose 9.49% Friday to close at $22.04. Its options trading volume was 1.18 million. Call contracts account for 71.8% of the total trading volume. The $22 calls expiring Aug. 30 were traded most actively.
Intel experienced a notable surge, climbing 9.9% to reach an intraday high of $22.12, following a report by Bloomberg News. The report, which cited "un...
No comment yet